TRANSCRIPT

Q3 2023 — Earnings call introductory remarks

Q3 2023PDF · 8 pages124 KB
1
CME Group 3Q 2023 Earnings Introductory Script
October 25, 2023
Adam Minick
Good morning, and I hope you are all doing well today. We will be
discussing CME Group’s third-quarter 2023 financial results. I will
start with the safe harbor language, then I'll turn it over to Terry.
Statements made on this call and in the other reference
documents on our website that are not historical facts are
forward-looking statements. These statements are not guarantees
of future performance. They involve risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual
outcomes and results may differ materially from what is
expressed or implied in any statement. Detailed information about
factors that may affect our performance can be found in the filings
with the SEC, which are on our website. Lastly, on the final page
of the earnings release, you will see a reconciliation between
GAAP and non-GAAP measures.
With that, I’ll turn the call over to Terry.

-- 1 of 8 --

2
Terrence A. Duffy
Thank you all for joining us this morning.
We released our executive commentary earlier today,
which provides details on the third quarter of 2023. I will
make a few brief comments on the quarter and current
outlook, and Lynne will summarize our financial results. In
addition to Lynne, we have other members of our
Management Team present to answer questions after the
prepared remarks.
Turning to the most recent quarter, average daily volume
of 22.3 million contracts was less than 1% off the record
Q3 high set in Q3 2022 while our revenue grew 9% to
$1.34 billion, which is the highest Q3 revenue in CME
Group’s history.
As we’ve mentioned throughout this year, we are
operating in an environment that unquestionably requires

-- 2 of 8 --

3
risk management. With so much uncertainty in the world
we live in, we’re continuing to work closely with our clients
to help them navigate uncertainty and manage their risks.
This is particularly true in the interest rate markets today.
We see divergent market views around inflation,
unemployment, monetary policy, and ongoing geopolitical
tension all impacting future interest rate expectations.
Regardless of whether rates rise, fall, or hold steady, the
shape of the yield curve and interest rate views continue
to shift, and our customers need to manage that risk.
As a result, we have continued to see growth on top of the
record year in 2022 for our interest rate business. This
was our highest Q3 for the interest rates complex, up 6%
from the same quarter last year. We saw particular
strength in the treasury complex which was up 16% in the
quarter and is off to a strong start in Q4 as well.

-- 3 of 8 --

4
Completing the successful migration of Eurodollars to
SOFR, we continue to list other products to complement
our interest rate complex.
• 	Our European Short-Term Rate – or €STR –
contracts traded a record 10k per day in
September.
• 	Our newly listed treasury bills futures launched on
October 2nd and have traded over 15k contracts in
the first three weeks. This is one of the most
successful launches of a rates product ever.
Our broad product offering and focus on capital
efficiencies, such as the enhanced cross margining
arrangement with DTCC going live in January 2024,
continue to enhance the value proposition for our
customers using our products to manage their interest rate
exposures.

-- 4 of 8 --

5
On the commodities side, third-quarter 2023 volume was
up 15% in total and included the highest-ever Q3 volume
for our agricultural products. Our energy complex also
performed well with volume increasing 16% from last year.
We believe the current environment for this asset class will
continue to bring new clients, as well as existing ones, to
manage their exposure in our global benchmark.
We believe the strong macro environment – combined
with our diverse set of asset classes, and strategic
execution across our growth initiatives – positions us well
for continued growth in 2023 and beyond.
With that, I’ll turn it over to Lynne to cover the third quarter
financial results.
Lynne Fitzpatrick
Thanks, Terry.

-- 5 of 8 --

6
During the third quarter, CME generated $1.34 billion in revenue,
up 9% compared to a strong third quarter of last year. Clearing
and Transaction fees and Market Data revenue each grew 9%
versus Q3 2022.
Expenses continue to be very carefully managed and on an
adjusted basis were $448 million for the quarter and $369 million
excluding license fees, both lower than second quarter this year.
This quarter our investment in our cloud migration was
approximately $13 million. Our adjusted operating margin for the
quarter expanded to 66.5%, up approximately 240 basis points
compared with the same period last year.
CME Group had an adjusted effective tax rate of 22.8%, which
resulted in net income of $818 million and adjusted diluted
earnings per share of $2.25, each up 14 percent from the third
quarter last year. Of the $110 million increase in revenue versus
last year, we were able to drive 90% to the bottom line with
adjusted net income up $99 million.
As a result of the strong expense discipline throughout the firm,
we are lowering our core expense guidance, excluding license

-- 6 of 8 --

7
fees, to $1.475 billion, a $15 million decrease from our original
guidance of $1.49 billion. We are maintaining our guidance of
$60 million for our cloud migration expense for a total expense
guidance of $1.535 billion excluding licensing fees.
We continue to manage our capital expenditures effectively and
with an eye towards our move to the cloud. As a result, we are
lowering our capex guidance to $85 million. For the quarter, our
capital expenditures were approximately $18 million.
CME paid out $2.8 billion of dividends so far this year and cash at
the end of the quarter was approximately $2.5 billion.
Our strong financial results this quarter continue to build on the
strength achieved in the first half of the year. This quarter we
delivered our 9th consecutive quarter of double digit adjusted
earnings growth. Our global benchmarks, data, and strong focus
on innovation and execution continue to address the needs of our
clients and deliver results for our shareholders.

-- 7 of 8 --

8
Please refer to the last page of our Executive Commentary for
additional financial highlights and details.
We'd like to now open up the call for your questions. Based on
the number of analysts covering us, please limit yourself to one
question, and then feel free to jump back into the queue.
Thank you.

-- 8 of 8 --